根据名称进行药物检索

Humulin R 与 Levofloxacin

Humulin R 与 Levofloxacin互相作用以及同时服用的可能性。

检测结果:

Humulin R <> Levofloxacin

现实性: 20.05.2022 评论家: 医学副博士Shkutko P.M., in

在该服务的官方手册中，已注明相关研究结果统计规定的互相作用。该互相作用或对患者健康引起不良后果，或起到良好效果。具体联合用药问题，需遵从医嘱。

用户:

等药物的左氧氟沙星有时会影响血液中的葡萄糖水平。这两个高血糖(高血糖)以及频率较低，低血糖(低血糖)的报告。严重的情况下的低血糖导致昏迷甚至死亡，尤其是在老年人和患有肾脏问题或者严重感染利用胰岛素的糖尿病或者其他药物，可以通常会导致低血糖。谈谈你的医生如果你有任何疑问或关切的问题。你的医生可以规定替代品，不进行互动，或者可能需要一剂量的调整或更频繁的监测你的血液中的葡萄糖水平安全地使用这两种药物。让你的医生知道如果你的经验低血糖或高血糖，或者如果你发现丢失血液中的葡萄糖的控制。低血糖症状包括头痛、头晕、睡意、紧张、混乱、震颤、恶心、饥饿、弱点、出汗，心悸，而快速的心跳。症状的高血糖可包括增加的渴望，增加了饥饿和增加排尿。重要的是要告诉你的医生关于所有其他药物的使用，包括维生素和草药。不停止使用任何药物，没有第一个说你的医生。

医界专家:

密切监测:诺酮抗生素可能干扰治疗作用的胰岛素和其他抗糖尿病剂。使用的种药物有关的干扰，在血液中的葡萄糖的动态平衡可能产生的影响的胰β细胞ATP敏感钾的渠道，调节胰岛素分泌. 这两个高血糖和血糖过低，已报告，通常是糖尿病患者的收伴随处理与口头降血糖药或胰岛素。虽然高血糖是显着更多的共同感染和本身可以是一个潜在的风险因素，低血糖可能导致更大的发病率和死亡率。内部安全审查进行的美国食品和药物管理局(FDA)确定了至少67报告的严重的相关的低血糖诺酮的使用导致昏迷状态、死亡或永久禁止的伤害，主要在老年人和糖尿病病人的肾损伤和/或复杂的感染。这是另外的众多情况下已经报告了沙星，这导致其撤出美国市场是在2008年。五种药物，FDA的行审查，左氧氟沙星不得不在大多数情况下(44)，其次通过环丙沙星(12)、莫西沙星(9)、氧氟沙星(2)和吉米沙星(0). 另一种药物，如萘啶酸和诺氟沙星，以及其他一些人，从来没有销售的或是不再销售，如clinafloxacin和temafloxacin，也已经与相关联dysglycemia，因此一般被认为是一类效果，尽管有不同的风险之中的个人剂。提供的数据似乎也表明不同的时间框架开展的防和高血糖，与前一般发生在1到3天以下的诺酮发起，而后者在4到10天之后。 Pharmacokinetically，环丙沙星也是一个已知的抑制剂的CYP450 1A2和3A4和可能抑制的肝新陈代谢的优降糖. 低血糖会升高的血清优降糖水平发生在患者一个星期之后的环丙沙星的治疗。

管理：血液中的葡萄糖应密切监测，每当种药物是按规定向糖尿病患者，特别是如果他们是老年人有肾脏损害，或严重虐待。由于风险的深远和潜在威胁生命的低血糖、特别谨慎建议期间同时使用的胰岛素和胰岛素分泌素(例如，磺酰脲，奈类). 病人也应该获悉的风险增加的低血糖和警觉到潜在的迹象和症状，例如头疼、头晕、睡意、紧张、混乱、震颤、饥饿、弱点、出汗，心悸，而性心动过速。如果是低血糖的出现，患者应开始适当的补救治疗，立即停止喹诺，并与他们的医生。替代的抗生素可能需要加以考虑。

来源

"Product Information. Cipro (ciprofloxacin)." Bayer, West Haven, CT.
Park-Wyllie LY, Juurlink DN, Kopp A, et al. "Outpatient gatifloxacin therapy and dysglycemia in older adults." N Engl J Med 354 (2006): 1352-61
Graumlich JF, Habis S, Avelino RR, et al. "Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study." Pharmacotherapy 25 (2005): 1296-302
Saraya A, Yokokura M, Gonoi T, Seino S "Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K(+) channels." Eur J Pharmacol 497 (2004): 111-7
Wang S, Rizvi AA "Levofloxacin-induced hypoglycemia in a nondiabetic patient." Am J Med Sci 331 (2006): 334-5
Bhasin R, Arce FC, Pasmantier R "Hypoglycemia associated with the use of gatifloxacin." Am J Med Sci 330 (2005): 250-3
"Product Information. Levaquin (levofloxacin)." Ortho Pharmaceutical Corporation, Raritan, NJ.
Zvonar R "Gatifloxacin-induced dysglycemia." Am J Health Syst Pharm 63 (2006): 2087-2092
"Product Information. Floxin (ofloxacin)." Ortho Pharmaceutical Corporation, Raritan, NJ.
Rubinstein E "History of quinolones and their side effects." Chemotherapy 47 Suppl 3 (2001): 3-8
LeBlanc M, Belanger C, Cossette P "Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy." Pharmacotherapy 24 (2004): 926-31
Biggs WS "Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients." J Am Board Fam Pract 16 (2004): 455-7
Brogan SE, Cahalan MK "Gatifloxacin as a possible cause of serious postoperative hypoglycemia." Anesth Analg 101 (2005): 635-6
Happe MR, Mulhall BP, Maydonovitch CL, Holtzmuller KC "Gatifloxacin-induced hyperglycemia." Ann Intern Med 141 (2004): 968-9
"Product Information. Raxar (grepafloxacin)." Glaxo Wellcome, Research Triangle Park, NC.
Kanbay M, Aydogan T, Bozalan R, et al. "A rare but serious side effect of levofloxacin: hypoglycemia in a geriatric patient." Diabetes Care 29 (2006): 1716-7
Gajjar DA, LaCreta FP, Kollia GD, et al. "Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise." Pharmacotherapy 20 (6 Pt 2) (2000): s76-86
Zhanel GG, Fontaine S, Adam H, et al. "A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections." Treat Respir Med 5 (2006): 437-465
Friedrich LV, Dougherty R "Fatal hypoglycemia associated with levofloxacin." Pharmacotherapy 24 (2004): 1807-12
Blommel AL, Lutes RA "Severe hyperglycemia during renally adjusted gatifloxacin therapy." Ann Pharmacother 39 (2005): 1349-52
"Product Information. Baxdela (delafloxacin)." Melinta Therapeutics, Lincolnshire, IL.
Baker SE, Hangii MC "Possible gatifloxacin-induced hypoglycemia." Ann Pharmacother 36 (2002): 1722-6
Yip C, Lee AJ "Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature." Clin Ther 28 (2006): 1857-66
Kelesidis T, Canseco E "Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect." Am J Med 123 (2010): e5-6
Letourneau G, Morrison H, McMorran M "Gatifloxacin (Tequin): hypoglycemia and hyperglycemia. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v13n3_e.html#1" ([2003 Jul]):
"Product Information. Tequin (gatifloxacin)" Bristol-Myers Squibb, Princeton, NJ.
Menzies DJ, Dorsainvil PA, Cunha BA, Johnson DH "Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents." Am J Med 113 (2002): 232-4
Gavin JR 3rd, Kubin R, Choudhri S, et al "Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies." Drug Saf 27 (2004): 671-86
"Hypoglycemia and hyperglycemia with fluoroquinolones." Med Lett Drugs Ther 45 (2003): 64
"Product Information. Noroxin (norfloxacin)." Merck & Co, Inc, West Point, PA.
Khovidhunkit W, Sunthornyothin S "Hypoglycemia, hyperglycemia, and gatifloxacin." Ann Intern Med 141 (2004): 969
Frothingham R "Glucose homeostasis abnormalities associated with use of gatifloxacin." Clin Infect Dis 41 (2005): 1269-76
Donaldson AR, Vandiver JR, Finch CK "Possible gatifloxacin-induced hyperglycemia." Ann Pharmacother 38 (2004): 602-5
Tomita T, Onishi M, Sato E, Kimura Y, Kihira K "Gatifloxacin induces augmented insulin release and intracellular insulin." Biol Pharm Bull 30 (2007): 644-7
"Product Information. Trovan (trovafloxacin)." Pfizer US Pharmaceuticals, New York, NY.
Edwards DJ, Bowles SK, Svensson CK, Rybak MJ "Inhibition of drug metabolism by quinolone antibiotics." Clin Pharmacokinet 15 (1988): 194-204
Lin G, Hays DP, Spillane L "Refractory hypoglycemia from ciprofloxacin and glyburide interaction." J Toxicol Clin Toxicol 42 (2004): 295-7
Greenberg AL, Decerbo M, Fan J "Gatifloxacin therapy associated with hypoglycemia." Clin Infect Dis 40 (2005): 1210-1
Roberge RJ, Kaplan R, Frank R, Fore C "Glyburide-ciprofloxacin interaction with resistant hypoglycemia." Ann Emerg Med 36 (2000): 160-3
"Product Information. Factive (gemifloxacin)." GeneSoft Inc, San Francisco, CA.